# PharmaCyte Biotech, Inc.: Form SC 13D, filed Nov 4, 2021

- Company: [PharmaCyte Biotech, Inc.](/companies/pmcb.md) (CIK 1157075)
- Form: SC 13D
- Filed: 2021-11-04
- Accepted by EDGAR: Nov 4, 2021, 07:38 ET
- Period: not reported
- Accession: 0000930413-21-001835
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1157075/000093041321001835/c102497_sc13d.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1157075/000093041321001835/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1157075/000093041321001835/c102497_sc13d.htm

Filed Nov 4, 2021.
Source: SEC EDGAR, the filing index for accession 0000930413-21-001835. Last ingested by Listed: Nov 14, 2026, 20:52 ET. No prices; not investment advice.
